Company:  LAUREATE EDUCATION, INC. (LAUR)
Form Type:  10-Q
Filing Date:  8/5/2021 
CIK:  0000912766 
Address:  650 S. EXETER STREET 
City, State, Zip:  BALTIMORE, Maryland 21202 
Telephone:  (410) 843-6100 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$17.13  
Change: 
-0.17 (-0.98%)  
Trade Time: 
Oct 18  
Market Cap: 
$1.97B
Trade LAUR now with 

© 2021  
Description of Business
Our Continuing Operations include Mexico and Peru. Unless otherwise indicated, the information in or incorporated by reference into this Form 10-K, including our segment information, relates only to our Continuing Operations. Strategic Developments On January 27, 2020, we announced that our board of directors had authorized the Company to explore strategic alternatives for each of its businesses to unlock shareholder value. During 2020, we made significant progress on this initiative. Laureate completed the sales of its operations in Chile, Malaysia, and Australia & New Zealand and signed definitive agreements to sell Walden University, its higher education institution in the U.S., as well as its operations in Brazil and Honduras. The Company expects to close the Brazil and Honduras transactions during the first half of the year. The closing for the Walden transaction is anticipated to occur in the second half of 2021.
Register and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      Item 1. Financial Statements (Unaudited)
        INCOME STATEMENT
        INCOME STATEMENT
        BALANCE SHEET
        BALANCE SHEET
        CASH FLOW
        Notes to Consolidated Financial Statements
          INCOME STATEMENT
          STOCKHOLDERS EQUITY
          STOCKHOLDERS EQUITY
          CASH FLOW
          Note 19. Subsequent Events
      Item 2. Management's Discussion and Analysis of Financial ...
      FINANCIAL STATEMENTS
        INCOME STATEMENT
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II - OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 31.1
  EXHIBIT 31.2
  EXHIBIT 32